The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global TCR-Based Antibody Market Research Report 2025
Synopsis
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
The global TCR-Based Antibody market was valued at US$ 930 million in 2023 and is anticipated to reach US$ 1787.4 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
North American market for TCR-Based Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for TCR-Based Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of TCR-Based Antibody include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for TCR-Based Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR-Based Antibody.
Report Scope
The TCR-Based Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global TCR-Based Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TCR-Based Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptimmune Therapeutics
Celgene
Immunocore
Kuur Therapeutics
Lion TCR
Kite Pharma
Takara Bio
Ziopharm Oncology
GlaxoSmithKline
Merck
Juno Theraprutics
Segment by Type
NY-ESO-1
p53
WT-1
EBv
Others
Segment by Application
Hospitals
Specialized Clinics
Pharma and Biotech Research Laboratories.
Gene Therapy Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of TCR-Based Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of TCR-Based Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
The global TCR-Based Antibody market was valued at US$ 930 million in 2023 and is anticipated to reach US$ 1787.4 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
North American market for TCR-Based Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for TCR-Based Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of TCR-Based Antibody include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for TCR-Based Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR-Based Antibody.
Report Scope
The TCR-Based Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global TCR-Based Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TCR-Based Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptimmune Therapeutics
Celgene
Immunocore
Kuur Therapeutics
Lion TCR
Kite Pharma
Takara Bio
Ziopharm Oncology
GlaxoSmithKline
Merck
Juno Theraprutics
Segment by Type
NY-ESO-1
p53
WT-1
EBv
Others
Segment by Application
Hospitals
Specialized Clinics
Pharma and Biotech Research Laboratories.
Gene Therapy Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of TCR-Based Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of TCR-Based Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 TCR-Based Antibody Market Overview
1.1 Product Overview and Scope of TCR-Based Antibody
1.2 TCR-Based Antibody Segment by Type
1.2.1 Global TCR-Based Antibody Market Value Comparison by Type (2024-2030)
1.2.2 NY-ESO-1
1.2.3 p53
1.2.4 WT-1
1.2.5 EBv
1.2.6 Others
1.3 TCR-Based Antibody Segment by Application
1.3.1 Global TCR-Based Antibody Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Pharma and Biotech Research Laboratories.
1.3.5 Gene Therapy Centers
1.3.6 Others
1.4 Global TCR-Based Antibody Market Size Estimates and Forecasts
1.4.1 Global TCR-Based Antibody Revenue 2019-2030
1.4.2 Global TCR-Based Antibody Sales 2019-2030
1.4.3 Global TCR-Based Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 TCR-Based Antibody Market Competition by Manufacturers
2.1 Global TCR-Based Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global TCR-Based Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global TCR-Based Antibody Average Price by Manufacturers (2019-2024)
2.4 Global TCR-Based Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of TCR-Based Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of TCR-Based Antibody, Product Type & Application
2.7 TCR-Based Antibody Market Competitive Situation and Trends
2.7.1 TCR-Based Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest TCR-Based Antibody Players Market Share by Revenue
2.7.3 Global TCR-Based Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 TCR-Based Antibody Retrospective Market Scenario by Region
3.1 Global TCR-Based Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global TCR-Based Antibody Global TCR-Based Antibody Sales by Region: 2019-2030
3.2.1 Global TCR-Based Antibody Sales by Region: 2019-2024
3.2.2 Global TCR-Based Antibody Sales by Region: 2025-2030
3.3 Global TCR-Based Antibody Global TCR-Based Antibody Revenue by Region: 2019-2030
3.3.1 Global TCR-Based Antibody Revenue by Region: 2019-2024
3.3.2 Global TCR-Based Antibody Revenue by Region: 2025-2030
3.4 North America TCR-Based Antibody Market Facts & Figures by Country
3.4.1 North America TCR-Based Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America TCR-Based Antibody Sales by Country (2019-2030)
3.4.3 North America TCR-Based Antibody Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe TCR-Based Antibody Market Facts & Figures by Country
3.5.1 Europe TCR-Based Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe TCR-Based Antibody Sales by Country (2019-2030)
3.5.3 Europe TCR-Based Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TCR-Based Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific TCR-Based Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific TCR-Based Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific TCR-Based Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America TCR-Based Antibody Market Facts & Figures by Country
3.7.1 Latin America TCR-Based Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America TCR-Based Antibody Sales by Country (2019-2030)
3.7.3 Latin America TCR-Based Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa TCR-Based Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa TCR-Based Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa TCR-Based Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa TCR-Based Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global TCR-Based Antibody Sales by Type (2019-2030)
4.1.1 Global TCR-Based Antibody Sales by Type (2019-2024)
4.1.2 Global TCR-Based Antibody Sales by Type (2025-2030)
4.1.3 Global TCR-Based Antibody Sales Market Share by Type (2019-2030)
4.2 Global TCR-Based Antibody Revenue by Type (2019-2030)
4.2.1 Global TCR-Based Antibody Revenue by Type (2019-2024)
4.2.2 Global TCR-Based Antibody Revenue by Type (2025-2030)
4.2.3 Global TCR-Based Antibody Revenue Market Share by Type (2019-2030)
4.3 Global TCR-Based Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global TCR-Based Antibody Sales by Application (2019-2030)
5.1.1 Global TCR-Based Antibody Sales by Application (2019-2024)
5.1.2 Global TCR-Based Antibody Sales by Application (2025-2030)
5.1.3 Global TCR-Based Antibody Sales Market Share by Application (2019-2030)
5.2 Global TCR-Based Antibody Revenue by Application (2019-2030)
5.2.1 Global TCR-Based Antibody Revenue by Application (2019-2024)
5.2.2 Global TCR-Based Antibody Revenue by Application (2025-2030)
5.2.3 Global TCR-Based Antibody Revenue Market Share by Application (2019-2030)
5.3 Global TCR-Based Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Adaptimmune Therapeutics
6.1.1 Adaptimmune Therapeutics Corporation Information
6.1.2 Adaptimmune Therapeutics Description and Business Overview
6.1.3 Adaptimmune Therapeutics TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Adaptimmune Therapeutics TCR-Based Antibody Product Portfolio
6.1.5 Adaptimmune Therapeutics Recent Developments/Updates
6.2 Celgene
6.2.1 Celgene Corporation Information
6.2.2 Celgene Description and Business Overview
6.2.3 Celgene TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celgene TCR-Based Antibody Product Portfolio
6.2.5 Celgene Recent Developments/Updates
6.3 Immunocore
6.3.1 Immunocore Corporation Information
6.3.2 Immunocore Description and Business Overview
6.3.3 Immunocore TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Immunocore TCR-Based Antibody Product Portfolio
6.3.5 Immunocore Recent Developments/Updates
6.4 Kuur Therapeutics
6.4.1 Kuur Therapeutics Corporation Information
6.4.2 Kuur Therapeutics Description and Business Overview
6.4.3 Kuur Therapeutics TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kuur Therapeutics TCR-Based Antibody Product Portfolio
6.4.5 Kuur Therapeutics Recent Developments/Updates
6.5 Lion TCR
6.5.1 Lion TCR Corporation Information
6.5.2 Lion TCR Description and Business Overview
6.5.3 Lion TCR TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lion TCR TCR-Based Antibody Product Portfolio
6.5.5 Lion TCR Recent Developments/Updates
6.6 Kite Pharma
6.6.1 Kite Pharma Corporation Information
6.6.2 Kite Pharma Description and Business Overview
6.6.3 Kite Pharma TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kite Pharma TCR-Based Antibody Product Portfolio
6.6.5 Kite Pharma Recent Developments/Updates
6.7 Takara Bio
6.6.1 Takara Bio Corporation Information
6.6.2 Takara Bio Description and Business Overview
6.6.3 Takara Bio TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takara Bio TCR-Based Antibody Product Portfolio
6.7.5 Takara Bio Recent Developments/Updates
6.8 Ziopharm Oncology
6.8.1 Ziopharm Oncology Corporation Information
6.8.2 Ziopharm Oncology Description and Business Overview
6.8.3 Ziopharm Oncology TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ziopharm Oncology TCR-Based Antibody Product Portfolio
6.8.5 Ziopharm Oncology Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GlaxoSmithKline TCR-Based Antibody Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Merck
6.10.1 Merck Corporation Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Merck TCR-Based Antibody Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Juno Theraprutics
6.11.1 Juno Theraprutics Corporation Information
6.11.2 Juno Theraprutics TCR-Based Antibody Description and Business Overview
6.11.3 Juno Theraprutics TCR-Based Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Juno Theraprutics TCR-Based Antibody Product Portfolio
6.11.5 Juno Theraprutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TCR-Based Antibody Industry Chain Analysis
7.2 TCR-Based Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TCR-Based Antibody Production Mode & Process
7.4 TCR-Based Antibody Sales and Marketing
7.4.1 TCR-Based Antibody Sales Channels
7.4.2 TCR-Based Antibody Distributors
7.5 TCR-Based Antibody Customers
8 TCR-Based Antibody Market Dynamics
8.1 TCR-Based Antibody Industry Trends
8.2 TCR-Based Antibody Market Drivers
8.3 TCR-Based Antibody Market Challenges
8.4 TCR-Based Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global TCR-Based Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global TCR-Based Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global TCR-Based Antibody Market Competitive Situation by Manufacturers in 2023
Table 4. Global TCR-Based Antibody Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global TCR-Based Antibody Sales Market Share by Manufacturers (2019-2024)
Table 6. Global TCR-Based Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global TCR-Based Antibody Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market TCR-Based Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of TCR-Based Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of TCR-Based Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of TCR-Based Antibody, Product Type & Application
Table 12. Global Key Manufacturers of TCR-Based Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global TCR-Based Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR-Based Antibody as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global TCR-Based Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global TCR-Based Antibody Sales by Region (2019-2024) & (K Units)
Table 18. Global TCR-Based Antibody Sales Market Share by Region (2019-2024)
Table 19. Global TCR-Based Antibody Sales by Region (2025-2030) & (K Units)
Table 20. Global TCR-Based Antibody Sales Market Share by Region (2025-2030)
Table 21. Global TCR-Based Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global TCR-Based Antibody Revenue Market Share by Region (2019-2024)
Table 23. Global TCR-Based Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global TCR-Based Antibody Revenue Market Share by Region (2025-2030)
Table 25. North America TCR-Based Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America TCR-Based Antibody Sales by Country (2019-2024) & (K Units)
Table 27. North America TCR-Based Antibody Sales by Country (2025-2030) & (K Units)
Table 28. North America TCR-Based Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America TCR-Based Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe TCR-Based Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe TCR-Based Antibody Sales by Country (2019-2024) & (K Units)
Table 32. Europe TCR-Based Antibody Sales by Country (2025-2030) & (K Units)
Table 33. Europe TCR-Based Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe TCR-Based Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific TCR-Based Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific TCR-Based Antibody Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific TCR-Based Antibody Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific TCR-Based Antibody Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific TCR-Based Antibody Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America TCR-Based Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America TCR-Based Antibody Sales by Country (2019-2024) & (K Units)
Table 42. Latin America TCR-Based Antibody Sales by Country (2025-2030) & (K Units)
Table 43. Latin America TCR-Based Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America TCR-Based Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa TCR-Based Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa TCR-Based Antibody Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa TCR-Based Antibody Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa TCR-Based Antibody Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa TCR-Based Antibody Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global TCR-Based Antibody Sales (K Units) by Type (2019-2024)
Table 51. Global TCR-Based Antibody Sales (K Units) by Type (2025-2030)
Table 52. Global TCR-Based Antibody Sales Market Share by Type (2019-2024)
Table 53. Global TCR-Based Antibody Sales Market Share by Type (2025-2030)
Table 54. Global TCR-Based Antibody Revenue (US$ Million) by Type (2019-2024)
Table 55. Global TCR-Based Antibody Revenue (US$ Million) by Type (2025-2030)
Table 56. Global TCR-Based Antibody Revenue Market Share by Type (2019-2024)
Table 57. Global TCR-Based Antibody Revenue Market Share by Type (2025-2030)
Table 58. Global TCR-Based Antibody Price (US$/Unit) by Type (2019-2024)
Table 59. Global TCR-Based Antibody Price (US$/Unit) by Type (2025-2030)
Table 60. Global TCR-Based Antibody Sales (K Units) by Application (2019-2024)
Table 61. Global TCR-Based Antibody Sales (K Units) by Application (2025-2030)
Table 62. Global TCR-Based Antibody Sales Market Share by Application (2019-2024)
Table 63. Global TCR-Based Antibody Sales Market Share by Application (2025-2030)
Table 64. Global TCR-Based Antibody Revenue (US$ Million) by Application (2019-2024)
Table 65. Global TCR-Based Antibody Revenue (US$ Million) by Application (2025-2030)
Table 66. Global TCR-Based Antibody Revenue Market Share by Application (2019-2024)
Table 67. Global TCR-Based Antibody Revenue Market Share by Application (2025-2030)
Table 68. Global TCR-Based Antibody Price (US$/Unit) by Application (2019-2024)
Table 69. Global TCR-Based Antibody Price (US$/Unit) by Application (2025-2030)
Table 70. Adaptimmune Therapeutics Corporation Information
Table 71. Adaptimmune Therapeutics Description and Business Overview
Table 72. Adaptimmune Therapeutics TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Adaptimmune Therapeutics TCR-Based Antibody Product
Table 74. Adaptimmune Therapeutics Recent Developments/Updates
Table 75. Celgene Corporation Information
Table 76. Celgene Description and Business Overview
Table 77. Celgene TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Celgene TCR-Based Antibody Product
Table 79. Celgene Recent Developments/Updates
Table 80. Immunocore Corporation Information
Table 81. Immunocore Description and Business Overview
Table 82. Immunocore TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Immunocore TCR-Based Antibody Product
Table 84. Immunocore Recent Developments/Updates
Table 85. Kuur Therapeutics Corporation Information
Table 86. Kuur Therapeutics Description and Business Overview
Table 87. Kuur Therapeutics TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Kuur Therapeutics TCR-Based Antibody Product
Table 89. Kuur Therapeutics Recent Developments/Updates
Table 90. Lion TCR Corporation Information
Table 91. Lion TCR Description and Business Overview
Table 92. Lion TCR TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Lion TCR TCR-Based Antibody Product
Table 94. Lion TCR Recent Developments/Updates
Table 95. Kite Pharma Corporation Information
Table 96. Kite Pharma Description and Business Overview
Table 97. Kite Pharma TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Kite Pharma TCR-Based Antibody Product
Table 99. Kite Pharma Recent Developments/Updates
Table 100. Takara Bio Corporation Information
Table 101. Takara Bio Description and Business Overview
Table 102. Takara Bio TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Takara Bio TCR-Based Antibody Product
Table 104. Takara Bio Recent Developments/Updates
Table 105. Ziopharm Oncology Corporation Information
Table 106. Ziopharm Oncology Description and Business Overview
Table 107. Ziopharm Oncology TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Ziopharm Oncology TCR-Based Antibody Product
Table 109. Ziopharm Oncology Recent Developments/Updates
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. GlaxoSmithKline TCR-Based Antibody Product
Table 114. GlaxoSmithKline Recent Developments/Updates
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Merck TCR-Based Antibody Product
Table 119. Merck Recent Developments/Updates
Table 120. Juno Theraprutics Corporation Information
Table 121. Juno Theraprutics Description and Business Overview
Table 122. Juno Theraprutics TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Juno Theraprutics TCR-Based Antibody Product
Table 124. Juno Theraprutics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. TCR-Based Antibody Distributors List
Table 128. TCR-Based Antibody Customers List
Table 129. TCR-Based Antibody Market Trends
Table 130. TCR-Based Antibody Market Drivers
Table 131. TCR-Based Antibody Market Challenges
Table 132. TCR-Based Antibody Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of TCR-Based Antibody
Figure 2. Global TCR-Based Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global TCR-Based Antibody Market Share by Type in 2023 & 2030
Figure 4. NY-ESO-1 Product Picture
Figure 5. p53 Product Picture
Figure 6. WT-1 Product Picture
Figure 7. EBv Product Picture
Figure 8. Others Product Picture
Figure 9. Global TCR-Based Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global TCR-Based Antibody Market Share by Application in 2023 & 2030
Figure 11. Hospitals
Figure 12. Specialized Clinics
Figure 13. Pharma and Biotech Research Laboratories.
Figure 14. Gene Therapy Centers
Figure 15. Others
Figure 16. Global TCR-Based Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global TCR-Based Antibody Market Size (2019-2030) & (US$ Million)
Figure 18. Global TCR-Based Antibody Sales (2019-2030) & (K Units)
Figure 19. Global TCR-Based Antibody Average Price (US$/Unit) & (2019-2030)
Figure 20. TCR-Based Antibody Report Years Considered
Figure 21. TCR-Based Antibody Sales Share by Manufacturers in 2023
Figure 22. Global TCR-Based Antibody Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest TCR-Based Antibody Players: Market Share by Revenue in 2023
Figure 24. TCR-Based Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global TCR-Based Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America TCR-Based Antibody Sales Market Share by Country (2019-2030)
Figure 27. North America TCR-Based Antibody Revenue Market Share by Country (2019-2030)
Figure 28. U.S. TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe TCR-Based Antibody Sales Market Share by Country (2019-2030)
Figure 31. Europe TCR-Based Antibody Revenue Market Share by Country (2019-2030)
Figure 32. Germany TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific TCR-Based Antibody Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific TCR-Based Antibody Revenue Market Share by Region (2019-2030)
Figure 39. China TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America TCR-Based Antibody Sales Market Share by Country (2019-2030)
Figure 50. Latin America TCR-Based Antibody Revenue Market Share by Country (2019-2030)
Figure 51. Mexico TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa TCR-Based Antibody Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa TCR-Based Antibody Revenue Market Share by Country (2019-2030)
Figure 56. Turkey TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E TCR-Based Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of TCR-Based Antibody by Type (2019-2030)
Figure 60. Global Revenue Market Share of TCR-Based Antibody by Type (2019-2030)
Figure 61. Global TCR-Based Antibody Price (US$/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of TCR-Based Antibody by Application (2019-2030)
Figure 63. Global Revenue Market Share of TCR-Based Antibody by Application (2019-2030)
Figure 64. Global TCR-Based Antibody Price (US$/Unit) by Application (2019-2030)
Figure 65. TCR-Based Antibody Value Chain
Figure 66. TCR-Based Antibody Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
